Literature DB >> 33993856

The COVID-19-designated hospitals in China: preparing for public health emergencies.

Qian Li1, Lin Wang1, Bangfang Wang2, Hongzhou Lu1.   

Abstract

The designated hospitals are another health approach besides Fangcang shelter hospitals and newly built temporary hospitals for responding to COVID-19 epidemic in China. Faced with the emergency situation, about 1512 hospitals from 363 cities have been designated in China to tackle the spread of COVID-19. They were local hospitals repurposed by the Chinese government as a regional public health response. Their comprehensive services mainly include: "fever-clinics" to screen patients, COVID-19 department for higher-levels of medical care, and makeshift wards for emergencies. As the only COVID-19 designated hospital in Shanghai, we documented three characters (Centralized response and action system, Comprehensive functions, Closed-Loop Management System) and three strategies (Resource allocation, Prevention of nosocomial infection, Management during the post-COVID-19 pandemic stage) from the experience in responding to COVID-19 pandemic. Lastly, learning the lessons from COVID-19 pandemic, a more efficacy and rapid national response to public health emergencies is required. Serving as an essential component of public health system, the COVID-19-designated hospitals should be always prepared for future emergencies.

Entities:  

Keywords:  COVID-19; centralized response and action system; emergencies; nosocomial infection; public health

Mesh:

Year:  2021        PMID: 33993856     DOI: 10.1080/22221751.2021.1931467

Source DB:  PubMed          Journal:  Emerg Microbes Infect        ISSN: 2222-1751            Impact factor:   7.163


  5 in total

1.  Italian National Recovery and Resilience Plan: a Healthcare Renaissance after the COVID-19 crisis?

Authors:  Tommaso Filippini; Silvio Roberto Vinceti
Journal:  Acta Biomed       Date:  2021-11-17

2.  Prevention and control of COVID-19 by primary health care facilities in China: a field-survey-based qualitative study in three typical cities.

Authors:  Yun-Yun Yan; Teng-Yang Fan; Yan-Ling Zheng; Hai-Qin Yang; Tian-Shu Li; Hai-Tang Wang; Yan-Feng Gu; Xue Xiao; Zhao-Hui Du; Xiao-Ming Sun
Journal:  BMC Health Serv Res       Date:  2022-03-26       Impact factor: 2.655

3.  Hymecromone: a clinical prescription hyaluronan inhibitor for efficiently blocking COVID-19 progression.

Authors:  Shuai Yang; Yun Ling; Fang Zhao; Wei Li; Zhigang Song; Lu Wang; Qiuting Li; Mengxing Liu; Ying Tong; Lu Chen; Daoping Ru; Tongsheng Zhang; Kaicheng Zhou; Baolong Zhang; Peng Xu; Zhicong Yang; Wenxuan Li; Yuanlin Song; Jianqing Xu; Tongyu Zhu; Fei Shan; Wenqiang Yu; Hongzhou Lu
Journal:  Signal Transduct Target Ther       Date:  2022-03-18

4.  Establishment of hospital resilience framework in urban China: insight from Wuhan City.

Authors:  Annan Jin; Gang Li; Yue Yu; Jiaobei Wang; Qifan Nie
Journal:  Comput Urban Sci       Date:  2022-09-15

5.  Information technology and artificial intelligence support in management experiences of the pediatric designated hospital during the COVID-19 2022 epidemic in Shanghai.

Authors:  Yu Shi; Jin Fu; Mei Zeng; Yanling Ge; Xiangshi Wang; Aimei Xia; Weijie Shen; Jiali Wang; Weiming Chen; Siyuan Jiang; Xiaowen Zhai
Journal:  Intell Med       Date:  2022-09-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.